Cleared Traditional

SEQUOIA SIGNATURE II DIAGNOSTIC ULTRASOUND SYSTEM (K022567) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K022567 · Acuson Corp. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2002
Decision
11d
Days
Class 2
Risk

K022567 is an FDA 510(k) clearance for the SEQUOIA SIGNATURE II DIAGNOSTIC ULTRASOUND SYSTEM. Classified as System, Imaging, Pulsed Doppler, Ultrasonic within the IYN classification (a category covering pulsed Doppler and ultrasound imaging systems), Class II - Special Controls.

Submitted by Acuson Corp. (Mountain View, US). The FDA issued a Cleared decision on August 13, 2002 after a review of 11 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1550 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Acuson Corp. devices

Submission Details

510(k) Number K022567 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 02, 2002
Decision Date August 13, 2002
Days to Decision 11 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
96d faster than avg
Panel avg: 107d · This submission: 11d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code IYN System, Imaging, Pulsed Doppler, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYN System, Imaging, Pulsed Doppler, Ultrasonic

All 609
Devices cleared under the same product code (IYN) and FDA review panel - the closest regulatory comparables to K022567.
ACUSON CV70 CARDIOVASCULAR SYSTEM
K032111 · Siemens Medical Solutions USA, Inc. · Jul 2003
GE VIVID 7, MODEL FC0003XX
K031663 · General Electric Co. · Jun 2003
SONOLINE ANTARES ULTRASOUND SYSTEM
K023720 · Siemens Medical Solutions USA, Inc. · Nov 2002
GE VIVID 3 EXPERT
K020789 · General Electric Co. · Apr 2002
LOGIQ 3
K020263 · General Electric Co. · Feb 2002
GE LOGIQ 5
K014097 · GE Medical Systems · Jan 2002